These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15929954)

  • 21. Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
    File TM; Lode H; Kurz H; Kozak R; Xie H; Berkowitz E;
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3323-31. PubMed ID: 15328092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB; Paglia M; Xiang J; Ambrose PG; Jones RN; Kahn JB
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
    Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
    Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.
    Iacopini F; Crispino P; Paoluzi OA; Consolazio A; Pica R; Rivera M; Palladini D; Nardi F; Paoluzi P
    Dig Liver Dis; 2005 Aug; 37(8):571-6. PubMed ID: 15996628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI; Bolzon LD; Turnak MR; Johns D; Henle SK; Allen BS
    Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.
    Niederman MS; Anzueto A; Sethi S; Choudhri S; Kureishi A; Haverstock D; Perroncel R
    Respir Med; 2006 Oct; 100(10):1781-90. PubMed ID: 16531032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin.
    Koeth LM; Good CE; Saunders KA; Jakielaszek C
    Int J Antimicrob Agents; 2004 Aug; 24(2):144-9. PubMed ID: 15288313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
    Siempos II; Dimopoulos G; Korbila IP; Manta K; Falagas ME
    Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of twice-daily amoxycillin/clavulanate in lower respiratory tract infections.
    Balgos AA; Rodriguez-Gomez G; Nasnas R; Mahasur AA; Margono BP; Tinoco-Favila JC; Sansores-Martinez RH; Hassan M; Beppo O; Wongsa A; Cukier A; Vargas F
    Int J Clin Pract; 1999; 53(5):325-30. PubMed ID: 10695094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
    Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
    Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
    Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
    Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis.
    Marple BF; Roberts CS; Frytak JR; Schabert VF; Wegner JC; Bhattacharyya H; Piccirillo JF; Sanchez SP
    Am J Otolaryngol; 2010; 31(1):1-8. PubMed ID: 19944891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.
    Arrieta A; Arguedas A; Fernandez P; Block SL; Emperanza P; Vargas SL; Erhardt WA; de Caprariis PJ; Rothermel CD
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3179-86. PubMed ID: 14506028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults.
    Adelglass J; DeAbate CA; McElvaine P; Fowler CL; LoCocco J; Campbell T
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):320-7. PubMed ID: 10064632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
    Paris R; Confalonieri M; Dal Negro R; Ligia GP; Mos L; Todisco T; Rastelli V; Perna G; Cepparulo M
    J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.